Suppr超能文献

五种新型 RB1 基因突变与中国儿童视网膜母细胞瘤的基因型-表型相关性。

Five novel RB1 gene mutations and genotype-phenotype correlations in Chinese children with retinoblastoma.

机构信息

Department of Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, People's Republic of China.

Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, People's Republic of China.

出版信息

Int Ophthalmol. 2022 Nov;42(11):3421-3430. doi: 10.1007/s10792-022-02341-2. Epub 2022 Aug 12.

Abstract

PURPOSE

To identify the spectrum of RB1 gene mutations in 114 Chinese patients with retinoblastoma.

METHODS

Genomic DNA was extracted from the peripheral blood of 114 Rb patients. Polymerase chain reactions (PCRs) followed by direct Sanger sequencing were used to screen for mutations in the RB1 gene, which contains 26 exons with flanking intronic sequences, except exon 15. Clinical data, including gender, age at diagnosis, laterality of ocular lesions, and associated symptoms, were recorded and compared.

RESULTS

We identified five novel mutations in the RB1 gene. Twenty-five other mutations found in this study have been previously reported. A higher rate of RB1 mutations, with 47.3% of mutations among bilaterally affected patients vs. 6.8% within unilaterally affected patients, was also observed (p < 0.0001). Bilaterally affected patients were diagnosed earlier when compared to unilaterally affected patients (11 ± 7 months versus 20 ± 14 months, p = 0.0002). Furthermore, nonsense mutations were abundant (n = 14), followed by frameshift mutations (n = 8), splicing site mutations (n = 5), while missense mutations were few (n = 3).

CONCLUSIONS

We found five novel mutations in RB1 genes, which expands the mutational spectrum of the gene. Children with bilateral Rb exhibited higher mutation rates and were diagnosed earlier than those with unilateral Rb. These findings will inform clinical diagnosis and genetic therapeutic targeting in Rb patients.

摘要

目的

鉴定 114 例中国视网膜母细胞瘤患者中 RB1 基因突变的谱。

方法

从 114 例 Rb 患者的外周血中提取基因组 DNA。采用聚合酶链反应(PCR)后直接 Sanger 测序,筛选 RB1 基因的突变,该基因包含 26 个外显子和侧翼内含子序列,除了外显子 15。记录并比较临床数据,包括性别、诊断时的年龄、眼部病变的侧别和相关症状。

结果

我们在 RB1 基因中发现了五个新的突变。本研究中发现的其他 25 个突变之前已有报道。还观察到 RB1 突变率较高,双侧受累患者的突变率为 47.3%,单侧受累患者的突变率为 6.8%(p<0.0001)。与单侧受累患者相比,双侧受累患者的诊断更早(11±7 个月与 20±14 个月,p=0.0002)。此外,无意义突变较多(n=14),其次是移码突变(n=8)、剪接位点突变(n=5),而错义突变较少(n=3)。

结论

我们在 RB1 基因中发现了五个新突变,扩展了该基因的突变谱。双侧 Rb 患儿的突变率较高,且诊断较早,单侧 Rb 患儿则较低。这些发现将为 Rb 患者的临床诊断和基因治疗靶点提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e1/9587959/919365aa3552/10792_2022_2341_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验